30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q14 Revenue: DePuy Synthes/Johnson & Johnson

$2,421MM, +3% (U.S. $1,292MM, +3%; ex-U.S. $1,129MM, +3%)

  • Hips +2% (U.S. +4%)
  • Knees +3% (U.S. +2%, ex-U.S. +6%)
  • Trauma +7% (U.S. +10%, ex-U.S. +4%))
  • Spine flat (U.S. -3%, ex-U.S. +4%)

 

  • Price pressure continued across all categories
  • U.S. pricing update: Hips -4.1%, positive mix to net -3.7%; Knees -2.4%, 2% positive mix for net 0.6%; Spine -3%, slight positive mix for net -0.08%; Trauma -0.7%, positive mix 2.5%, net 1.8%
  • Growth from ATTUNE knee launch partially offset by price pressure and soft U.S. market